Four-year long-term drug survival of dupilumab analyzed by treatment period in patients with moderate to severe atopic dermatitis: A real-world retrospective study.
J Dermatol
; 51(3): e63-e65, 2024 Mar.
Article
in En
| MEDLINE
| ID: mdl-37950501
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Dermatitis, Atopic
Limits:
Humans
Language:
En
Journal:
J Dermatol
Year:
2024
Document type:
Article